ZHBIO(300653)2025-04-22 10:20Financial Performance - In Q1 2025, the company achieved total revenue of 97.42 million yuan, an increase of 8.68% compared to the same period last year [1] - The net profit attributable to shareholders was 26.63 million yuan, a decrease of 34.06% year-on-year [1] - Earnings per share stood at 0.15 yuan [1] Market Position and Competition - The company’s oral product sales have seen a year-on-year increase in Q1 2025, despite missing previous opportunities in the dental implant market [3] - Competitors in the orthopedic sector are actively developing next-generation products, indicating a need for the company to maintain a sense of urgency in its active bone sales [3][4] - The market for bone repair materials is expected to grow steadily, benefiting from the increasing demand in China [4] Product Development and Strategy - The company plans to promote its active biological bone products in UBE surgical applications, leveraging its unique technology that prevents BMP-2 diffusion in water environments [3][4] - There are ongoing efforts to expand the product line, including potential new product development and market entry strategies [4][5] - The company is considering mergers and acquisitions to enhance its product offerings and market presence [4] Sales and Marketing - The company has an independent sales team focused on promoting active biological bone products, with plans to enhance their professional capabilities [6] - The number of distributors has increased to over 1,410 nationwide as of 2024 [7] - The company is committed to a precision marketing strategy to strengthen its market share and brand recognition [6][8] Future Outlook - The company remains optimistic about the future of regenerative medicine and is expanding its technical platforms to include additive manufacturing and synthetic biology [5] - New products, such as the second-generation oral repair membrane and calcium silicate biological bone materials, are expected to enhance the company’s market position [8] - The company is actively monitoring industry trends and regulatory changes to adapt its strategies accordingly [4][8]